![Charles Theuer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 413 088 $ au 31/05/2026
Dr. Charles P.
Theuer is a Chief Medical Officer at Halozyme Therapeutics, Inc., an Independent Director at Oncternal Therapeutics, Inc. and an Independent Director at 4D Molecular Therapeutics, Inc. He is on the Board of Directors at Oncternal Therapeutics, Inc. and 4D Molecular Therapeutics, Inc. Dr. Theuer was previously employed as a President, Chief Executive Officer & Director by TRACON Pharmaceuticals, Inc., a Chief Medical Officer & VP-Clinical Development by TargeGen, Inc., a Director-Clinical Oncology by Pfizer Inc., a Principal by National Cancer Institute, and an Assistant Professor-Surgical Oncology by University of California, Irvine.
He received his undergraduate degree from Massachusetts Institute of Technology, a doctorate degree from the University of California, Irvine and a doctorate degree from The University of California, San Francisco.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 41 684 ( 0,08 % ) | 413 088 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/12/2015 |
| ONCTERNAL THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/05/2018 |
| HALOZYME THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/10/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| TRACON PHARMACEUTICALS, INC. | Directeur Général | 31/07/2024 |
TargeGen, Inc.
 TargeGen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures vascular biopharmaceutical products | Directeur Technique/Scientifique/R&D | 01/01/2006 |
| PFIZER INC. | Corporate Officer/Principal | 01/01/2004 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | 01/01/1993 |
University of California, Irvine
 University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
TargeGen, Inc.
TargeGen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures vascular biopharmaceutical products | Health Technology |
TRACON Pharmaceuticals, Inc.
 TRACON Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel targeted therapeutics for cancer treatment | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of California, Irvine
University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
4D Molecular Therapeutics, Inc.
 4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Oncternal Therapeutics, Inc.
 Oncternal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that manufactures pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
